Angiogenesis	0	12	O
:	12	13	O
initiation	14	24	O
and	25	28	O
control	29	36	O
.	36	37	O

From	39	43	O
in	44	46	O
vivo	47	51	O
experiments	52	63	O
using	64	69	O
new	70	73	O
methods	74	81	O
such	82	86	O
as	87	89	O
the	90	93	O
rabbit	94	100	B-Organism
cornea	101	107	B-Multi-tissue_structure
,	107	108	O
it	109	111	O
is	112	114	O
now	115	118	O
becoming	119	127	O
clear	128	133	O
that	134	138	O
the	139	142	O
growth	143	149	O
of	150	152	O
a	153	154	O
capillary	155	164	B-Tissue
involves	165	173	O
an	174	176	O
ordered	177	184	O
sequence	185	193	O
of	194	196	O
events	197	203	O
that	204	208	O
includes	209	217	O
lysis	218	223	O
of	224	226	O
the	227	230	O
basement	231	239	B-Cellular_component
membrane	240	248	I-Cellular_component
of	249	251	O
a	252	253	O
parent	254	260	O
venule	261	267	B-Multi-tissue_structure
,	267	268	O
directional	269	280	O
migration	281	290	O
of	291	293	O
capillary	294	303	B-Cell
endothelial	304	315	I-Cell
cells	316	321	I-Cell
toward	322	328	O
the	329	332	O
angiogenic	333	343	O
stimulus	344	352	O
,	352	353	O
lumen	354	359	B-Immaterial_anatomical_entity
formation	360	369	O
,	369	370	O
development	371	382	O
of	383	385	O
branches	386	394	B-Tissue
,	394	395	O
and	396	399	O
anastomosis	400	411	O
of	412	414	O
the	415	418	O
tip	419	422	O
of	423	425	O
one	426	429	O
tube	430	434	B-Tissue
with	435	439	O
another	440	447	O
to	448	450	O
form	451	455	O
a	456	457	O
loop	458	462	O
.	462	463	O

It	464	466	O
is	467	469	O
also	470	474	O
clear	475	480	O
that	481	485	O
diffusible	486	496	O
angiogenic	497	507	O
stimuli	508	515	O
can	516	519	O
be	520	522	O
released	523	531	O
not	532	535	O
only	536	540	O
from	541	545	O
most	546	550	O
solid	551	556	B-Pathological_formation
tumors	557	563	I-Pathological_formation
,	563	564	O
but	565	568	O
also	569	573	O
from	574	578	O
at	579	581	O
least	582	587	O
three	588	593	O
non	594	597	B-Cell
-	597	598	I-Cell
neoplastic	598	608	I-Cell
cells	609	614	I-Cell
.	614	615	O

These	616	621	O
include	622	629	O
activated	630	639	O
macrophages	640	651	B-Cell
,	651	652	O
sensitized	653	663	O
lymphocytes	664	675	B-Cell
,	675	676	O
and	677	680	O
adipocytes	681	691	B-Cell
.	691	692	O

Other	693	698	O
normal	699	705	B-Tissue
tissues	706	713	I-Tissue
can	714	717	O
also	718	722	O
stimulate	723	732	O
angiogenesis	733	745	O
,	745	746	O
but	747	750	O
the	751	754	O
type	755	759	O
of	760	762	O
cell	763	767	B-Cell
giving	768	774	O
rise	775	779	O
to	780	782	O
the	783	786	O
angiogenic	787	797	O
stimulus	798	806	O
is	807	809	O
unknown	810	817	O
,	817	818	O
and	819	822	O
the	823	826	O
period	827	833	O
of	834	836	O
angiogenic	837	847	O
stimulation	848	859	O
is	860	862	O
brief	863	868	O
.	868	869	O

With	870	874	O
the	875	878	O
recent	879	885	O
ability	886	893	O
to	894	896	O
clone	897	902	O
capillary	903	912	B-Cell
endothelial	913	924	I-Cell
cells	925	930	I-Cell
and	931	934	O
to	935	937	O
carry	938	943	O
them	944	948	O
in	949	951	O
long	952	956	O
-	956	957	O
term	957	961	O
culture	962	969	O
,	969	970	O
it	971	973	O
has	974	977	O
been	978	982	O
possible	983	991	O
to	992	994	O
further	995	1002	O
delineate	1003	1012	O
the	1013	1016	O
mechanism	1017	1026	O
of	1027	1029	O
capillary	1030	1039	B-Tissue
growth	1040	1046	O
.	1046	1047	O

In	1048	1050	O
vitro	1051	1056	O
studies	1057	1064	O
have	1065	1069	O
shown	1070	1075	O
that	1076	1080	O
the	1081	1084	O
mast	1085	1089	B-Cell
cell	1090	1094	I-Cell
seems	1095	1100	O
to	1101	1103	O
behave	1104	1110	O
as	1111	1113	O
a	1114	1115	O
helper	1116	1122	B-Cell
cell	1123	1127	I-Cell
for	1128	1131	O
capillary	1132	1141	B-Cell
endothelial	1142	1153	I-Cell
cells	1154	1159	I-Cell
,	1159	1160	O
in	1161	1163	O
some	1164	1168	O
way	1169	1172	O
speeding	1173	1181	O
up	1182	1184	O
their	1185	1190	O
rate	1191	1195	O
of	1196	1198	O
directional	1199	1210	O
migration	1211	1220	O
.	1220	1221	O

At	1222	1224	O
this	1225	1229	O
writing	1230	1237	O
,	1237	1238	O
heparin	1239	1246	B-Drug_or_compound
appears	1247	1254	O
to	1255	1257	O
be	1258	1260	O
the	1261	1264	O
principal	1265	1274	O
mast	1275	1279	B-Cell
cell	1280	1284	I-Cell
factor	1285	1291	O
responsible	1292	1303	O
for	1304	1307	O
this	1308	1312	O
effect	1313	1319	O
on	1320	1322	O
capillary	1323	1332	B-Cell
endothelial	1333	1344	I-Cell
cells	1345	1350	I-Cell
.	1350	1351	O

One	1352	1355	O
theoretical	1356	1367	O
possibility	1368	1379	O
is	1380	1382	O
that	1383	1387	O
mast	1388	1392	B-Cell
cells	1393	1398	I-Cell
may	1399	1402	O
prepare	1403	1410	O
the	1411	1414	O
matrix	1415	1421	B-Cellular_component
,	1421	1422	O
perhaps	1423	1430	O
by	1431	1433	O
slow	1434	1438	O
release	1439	1446	O
of	1447	1449	O
heparin	1450	1457	B-Drug_or_compound
,	1457	1458	O
so	1459	1461	O
that	1462	1466	O
capillary	1467	1476	B-Tissue
sprouts	1477	1484	I-Tissue
can	1485	1488	O
more	1489	1493	O
easily	1494	1500	O
move	1501	1505	O
through	1506	1513	O
it	1514	1516	O
toward	1517	1523	O
their	1524	1529	O
angiogenic	1530	1540	O
target	1541	1547	O
.	1547	1548	O

While	1549	1554	O
the	1555	1558	O
study	1559	1564	O
of	1565	1567	O
angiogenesis	1568	1580	O
as	1581	1583	O
a	1584	1585	O
phenomenon	1586	1596	O
is	1597	1599	O
still	1600	1605	O
in	1606	1608	O
an	1609	1611	O
early	1612	1617	O
phase	1618	1623	O
,	1623	1624	O
it	1625	1627	O
has	1628	1631	O
become	1632	1638	O
possible	1639	1647	O
,	1647	1648	O
by	1649	1651	O
using	1652	1657	O
a	1658	1659	O
combination	1660	1671	O
of	1672	1674	O
in	1675	1677	O
vitro	1678	1683	O
and	1684	1687	O
in	1688	1690	O
vivo	1691	1695	O
techniques	1696	1706	O
,	1706	1707	O
to	1708	1710	O
more	1711	1715	O
thoroughly	1716	1726	O
understand	1727	1737	O
the	1738	1741	O
initiation	1742	1752	O
and	1753	1756	O
control	1757	1764	O
of	1765	1767	O
capillary	1768	1777	B-Tissue
growth	1778	1784	O
.	1784	1785	O

